Gabriel Contreras - Concepedia

Author

Gabriel Contreras

Also Known As

, Contreras, G., G Contreras, G. Contreras, G., Contreras, GABRIEL N. CONTRERAS, Gabriel Contreras, Gabriel N. Contreras, Isenberg, David, Jayne, David

148

Publications

11.4K

Citations

H-Index

101

Concepts

All Affiliations

University of Miami Johns Hopkins University The Ohio State University Cleveland Clinic National Institutes of Health

About

Gabriel Contreras is an author at University of Miami specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	35	3.7K
2	Public Health	8	8	335
3	African American Studies	2	2	215
4	Allergy	1	1	27
5	Biochemistry	1	1	148

Gabriel Contreras

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis Gerald B. Appel, Gabriel Contreras, Mary Anne Dooley, Journal of the American Society of Nephrology GlomerulonephritisMycophenolate MofetilRenal FunctionAutoimmune DiseaseSystemic Lupus Erythematosus Treatment	2009	1.1K
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis Richard Furie, Brad H. Rovin, Frédéric Houssiau, New England Journal of Medicine	2020	903
Sequential Therapies for Proliferative Lupus Nephritis Gabriel Contreras, Victoriano Pardo, Baudouin Leclercq, New England Journal of Medicine	2004	817
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease Lawrence J. Appel, Jackson T. Wright, Tom Greene, New England Journal of Medicine	2010	712
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis Mary Anne Dooley, David Jayne, Ellen M. Ginzler, New England Journal of Medicine	2011	625
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study David Isenberg, Gerald B. Appel, Gabriel Contreras, Lara D. Veeken	2009	350
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach Crystal A. Gadegbeku, Debbie S. Gipson, Lawrence B. Holzman, Kidney International Glomerular DiseaseMultidisciplinary ApproachRenal PathologyDiagnosisGlomerulonephritis	2013	345
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States Jennifer E. Flythe, Magdalene M. Assimon, Matthew J. Tugman, American Journal of Kidney Diseases HemodialysisIntensive Care UnitsMedicineKidney FailureAcute Care	2020	231
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Factors associated with poor outcomes in patients with lupus nephritis Gabriel Contreras, Victoriano Pardo, Cesar Cely, Lupus Glomerular DiseaseGlomerulonephritisRenal FunctionIga GlomerulonephritisPoor Outcomes	2005	217

Page 1